EU Will End Vaccine Export Controls Dec. 31
The European Union extended its COVID-19 vaccine export transparency and authorization system until Dec. 31 and intends no further extensions, the European Commission said Sept. 30. The system was intended to ensure that vaccine manufacturers in Europe fulfill their contractual…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
obligations with the EU and applies only to companies with which the EU has negotiated an advance purchase agreement. The controls require these companies to notify their member state authorities of their intention to export COVID-19 vaccines. Beginning Jan. 1, 2022, the commission will use a new monitoring system that will give company-specific and timely vaccine export data, the commission said. This will ensure transparency without export controls, it said.